Mga Batayang Estadistika
CIK | 1803977 |
SEC Filings
SEC Filings (Chronological Order)
September 4, 2025 |
Exhibit 99.1 Limitless X Holdings Issues Shareholder Letter Detailing Strategic Transformation, Reg A+ Qualification, Capital Markets Milestones, and Near-Term Growth Outlook LOS ANGELES, CA – September 03, 2025 – Limitless X Holdings, Inc. (OTCQX: LIMX). Dear Valued Shareholders, On behalf of the Board of Directors and Management Team at Limitless X Holdings, Inc., I am pleased to share an import |
|
September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 3, 2025 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commiss |
|
August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
August 1, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form 1-A/A of our report dated May 9, 2025 relating to the financial statements which appeared in Limitless X Holdings, Inc. Annual Report on Form 10-K as of and for the years ended December 31, 2024 and 2023 and the reference to our firm under |
|
August 1, 2025 |
Offering Circular dated August 1, 2025 File No. 024-12574 Offering Circular dated August 1, 2025 An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering Statement filed with the Commiss |
|
August 1, 2025 |
Exhibit 4.1 SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made and entered into as of the date of execution by the undersigned subscriber, by and between Limitless X Holdings Inc., a Delaware corporation (the “Company”), and the undersigned individual or entity (the “Subscriber”). RECITALS WHEREAS, the Company is offering for sale up to a maximum of 3,000,000 shares of i |
|
August 1, 2025 |
Exhibit 12.1 August 1, 2025 Board of Directors Limitless X Holdings Inc. 9777 Wilshire Blvd., Suite 400, Beverly Hills, CA 90212 To the Board of Directors: We have acted as counsel to Limitless X Holdings Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing of its offering statement on Form 1-A/A, (the “Offering Statement”) with the Securities and Exchange Co |
|
July 18, 2025 |
Offering Circular dated July __, 2025 File No. 024-12574 Offering Circular dated July , 2025 An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering Statement filed with the Commission |
|
July 18, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form 1-A/A of our report dated May 9, 2025 relating to the financial statements which appeared in Limitless X Holdings, Inc. Annual Report on Form 10-K as of and for the years ended December 31, 2024 and 2023 and the reference to our firm under |
|
July 18, 2025 |
Exhibit 12.1 July 17, 2025 Board of Directors Limitless X Holdings Inc. 9777 Wilshire Blvd., Suite 400, Beverly Hills, CA 90212 To the Board of Directors: We have acted as counsel to Limitless X Holdings Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing of its offering statement on Form 1-A/A, (the “Offering Statement”) with the Securities and Exchange Com |
|
July 14, 2025 |
Promissory Note dated July 11, 2025 by and between the Company and EM1 Capital LLC Exhibit 10.1 RELATED PARTY LOAN AGREEMENT AND PROMISSORY NOTE $250,000.00 July 11, 2025 (“Effective Date”) 12-Month Note 1. LOAN AMOUNT Principal Loan Amount: Subject to the terms and conditions herein, EMl Capital LLC (“EM1” or “Holder”) has agreed to advance a loan in favor of Limitless X Holdings, Inc., a Delaware corporation (“LIMX” or “Maker”) the total sum of Two Hundred Fifty Thousand Dolla |
|
July 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 11, 2025 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commission |
|
July 14, 2025 |
Warrant Agreement dated July 11, 2025 by and between the Company and EM1 Capital LLC Exhibit 10.2 Warrant No. July 11, 2025 WARRANT To Purchase Five Hundred Thousand (500,000) Shares of Common Stock of LIMITLESS X HOLDINGS INC. July 11, 2025 (“Issuance Date”) THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES |
|
July 11, 2025 |
Exhibit 12.1 July 11, 2025 Board of Directors Limitless X Holdings Inc. 9777 Wilshire Blvd., Suite 400, Beverly Hills, CA 90212 To the Board of Directors: We have acted as counsel to Limitless X Holdings Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing of its offering statement on Form 1-A/A, (the “Offering Statement”) with the Securities and Exchange Com |
|
July 11, 2025 |
Offering Circular dated July __, 2025 File No. 024-12574 Offering Circular dated July , 2025 An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering Statement filed with the Commission |
|
July 11, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form 1-A/A of our report dated May 9, 2025 relating to the financial statements which appeared in Limitless X Holdings, Inc. Annual Report on Form 10-K as of and for the years ended December 31, 2024 and 2023 and the reference to our firm under |
|
July 7, 2025 |
Offering Circular dated July __, 2025 File No. 024-12574 Offering Circular dated July , 2025 An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering Statement filed with the Commission |
|
July 7, 2025 |
Exhibit 6.34 |
|
July 7, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form 1-A/A of our report dated May 9, 2025 relating to the financial statements which appeared in Limitless X Holdings, Inc. Annual Report on Form 10-K as of and for the years ended December 31, 2024 and 2023 and the reference to our firm under |
|
July 7, 2025 |
Exhibit 6.33 |
|
July 7, 2025 |
Exhibit 6.35 |
|
July 7, 2025 |
Exhibit 12.1 July 7, 2025 Board of Directors Limitless X Holdings Inc. 9777 Wilshire Blvd., Suite 400, Beverly Hills, CA 90212 To the Board of Directors: We have acted as counsel to Limitless X Holdings Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing of its offering statement on Form 1-A/A, (the “Offering Statement”) with the Securities and Exchange Comm |
|
June 13, 2025 |
Promissory Note dated June 11, 2025 between the Company and EM1 Capital LLC (Promissory Note 2) Exhibit 10.2 PROMISSORY NOTE $75,000.00 Wilmington, Delaware Maturity Date: Six Months (or on funding) Effective Date: June 11, 2025 1. LOAN AMOUNT Principal Loan Amount: The sum of $75,000 (“Loan Amount” or “Loan”) payable in favor of Limitless X Holdings Inc. (the “Maker”), specifically used for necessary expenses, will be paid by EM1 Capital LLC in full between the Effective Date and June 23, 2 |
|
June 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 9, 2025 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commission F |
|
June 13, 2025 |
Exhibit 10.1 PROMISSORY NOTE $25,000.00 Los Angeles, California Maturity Date: December 9, 2025 Effective Date: June 9, 2025 1. LOAN AMOUNT Principal Loan Amount: The sum of $25,000.00 payable in favor of Limitless X Inc. specifically for the auditing expense for the Regulation A Offering Circular and other auditing fees, paid by EM1 Capital LLC directly in full as of the Effective Date hereof. 2. |
|
June 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A (AMENDMENT NO. |
|
June 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A (AMENDMENT NO. |
|
May 30, 2025 |
BRIDGE LOAN AGREEMENT BY AND BETWEEN LIMITLESS FILMS, INC. AND GENTLEMAN THIEF LLC Exhibit 6.25 BRIDGE LOAN AGREEMENT BY AND BETWEEN LIMITLESS FILMS, INC. AND GENTLEMAN THIEF LLC |
|
May 30, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form 1-A/A of our report dated May 9, 2025 relating to the financial statements which appeared in Limitless X Holdings, Inc. Annual Report on Form 10-K as of and for the years ended December 31, 2024 and 2023 and the reference to our firm under |
|
May 30, 2025 |
Exhibit 12.1 May 29, 2025 Board of Directors Limitless X Holdings Inc. 9777 Wilshire Blvd., Suite 400, Beverly Hills, CA 90212 To the Board of Directors: We have acted as counsel to Limitless X Holdings Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing of its offering statement on Form 1-A/A, (the “Offering Statement”) with the Securities and Exchange Comm |
|
May 30, 2025 |
Offering Circular dated May 29, 2025 File No. 024-12574 Offering Circular dated May 29, 2025 An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering Statement filed with the Commissio |
|
May 22, 2025 |
Second Amendment to the Manufacturing and Distributorship License Agreement Exhibit 10.1 |
|
May 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
May 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 20, 2025 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commission F |
|
May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-56453 CUSIP NUMBER 090622309 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 20 |
|
May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 000-56453 Commission File Number LIMITLESS X HOL |
|
May 9, 2025 |
Certification of Incorporation, as amended. Exhibit 3.1 |
|
April 16, 2025 |
Vendor Debt Conversion Agreement with Emblaze One, Inc. Exhibit 10.2 DEBT CONVERSION AGREEMENT This Debt Conversion Agreement (referred to as this “Agreement”), dated as of April 14, 2025 (the “Closing Date”) is entered into by and between Limitless X Holdings, Inc., a Delaware corporation (the “Company”), and Emblaze One, Inc., (the “Creditor”). The parties to this Agreement may be referred to individually as a “Party” and collectively as the “Parties |
|
April 16, 2025 |
Vender Debt Conversion Agreement EM1 Capital LLC Exhibit 10.3 DEBT CONVERSION AGREEMENT This Debt Conversion Agreement (referred to as this “Agreement”), dated as of April 14, 2025 (the “Closing Date”) is entered into by and between Limitless X Holdings, Inc., a Delaware corporation (the “Company”), and EM1 Capital LLC (the “Creditor”). The parties to this Agreement may be referred to individually as a “Party” and collectively as the “Parties.” |
|
April 16, 2025 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 14, 2025 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commission |
|
April 16, 2025 |
Vendor Debt Conversoin Agreement with Jaspreet Mathur Exhibit 10.1 DEBT CONVERSION AGREEMENT This Debt Conversion Agreement (referred to as this “Agreement”), dated as of April 14, 2025 (the “Closing Date”) is entered into by and between Limitless X Holdings, Inc., a Delaware corporation (the “Company”), and Jaspreet Mathur (the “Creditor”). The parties to this Agreement may be referred to individually as a “Party” and collectively as the “Parties.” |
|
April 14, 2025 |
Exhibit 6.22 FUNDING COMMITMENT AGREEMENT This FUNDING COMMITMENT AGREEMENT (this “Agreement”) is entered into on June 3, 2023 (the “Effective Date”) by and between Limitless X Holdings Inc., a Delaware corporation (the “Company”) and Jaspreet Mathur, an individual (the “Lender”). WHEREAS, the Company seeks working capital for the Company in order to continue to move forward with its business plan |
|
April 14, 2025 |
AGREEMENT APPOINTING MOUNTAIN SHARE TRANSFER, LLC. AS TRANSFER AGENT AND REGISTRANT Exhibit 6.23 AGREEMENT APPOINTING MOUNTAIN SHARE TRANSFER, LLC. AS TRANSFER AGENT AND REGISTRANT This agreement is made this 5th day of September, 2019 between Mountain Share Transfer, LLC., a Georgia limited liability company, herein referred to as MST, and Bio Labs Naturals, Inc. a Nevada corporation, herein referred to as the Company. 1. Appointment. MST is hereby appointed transfer agent and r |
|
April 14, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form 1-A/A of our report dated December 2, 2024 relating to the financial statements which appeared in Limitless X Holdings, Inc. Annual Report on Form 10-K/A for the years ended December 31, 2022 and December 31, 2023. /s/ M&K CPA’s, PLLC The |
|
April 14, 2025 |
Exhibit 4.1 NOTICE TO INVESTORS THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK, SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. INVESTORS SHOULD FURTHER UNDERSTAND THAT THIS INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. THE SECURITIES OFFERED HEREBY HA |
|
April 14, 2025 |
Offering Circular dated April 11, 2025 File No. 024-12515 Offering Circular dated April 11, 2025 An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering Statement filed with the Commiss |
|
April 14, 2025 |
Exhibit 12.1 April 11, 2025 Board of Directors Limitless X Holdings Inc. 9777 Wilshire Blvd., Suite 400, Beverly Hills, CA 90212 To the Board of Directors: We have acted as counsel to Limitless X Holdings Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing of its offering statement on Form 1-A/A, (the “Offering Statement”) with the Securities and Exchange Co |
|
April 7, 2025 |
Letter dated April 4, 2025 from M&K CPAS, PLLC to the Securities and Exchange Commission Exhibit 13.1 April 4, 2025 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Ladies and Gentlemen: We have read the statements made Limitless X Holdings Inc. (the “Company”), set forth in Item 4.02 of the Company’s Current Report on Form 8-K, dated April 4, 2025 (the “Form 8-K”). We agree with the statements concerning our Firm contained in such Item 4.02. Very truly yours, / |
|
April 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 1, 2024 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commissi |
|
April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response....2.50 FORM 12b-25 SEC FILE NUMBER 000-56453 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ T |
|
March 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 21, 2025 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commission |
|
March 25, 2025 |
Promissory Note dated March 21, 2025 between the Company and the Holder Exhibit 10.1 PROMISSORY NOTE $500,000.00 Wilmington, Delaware Maturity Date: Six Months (or on funding) Effective Date: March 21, 2025 1. LOAN AMOUNT Principal Loan Amount: The sum of $500,000 (“Loan Amount” or “Loan”) payable in favor of Limitless X Holdings Inc. (the “Maker”) specifically for payments made by Jaspreet Mathur for legal fees incurred by the Maker’s securities counsel ($200,000), e |
|
February 14, 2025 |
Exhibit 6.18 |
|
February 14, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form 1-A of our report dated December 2, 2024 relating to the audit of the consolidated financial statements as of December 31, 2023 and 2022, and for the periods then ended, and the reference to our firm under the caption “Experts” in the Regi |
|
February 14, 2025 |
Exhibit 4.1 NOTICE TO INVESTORS THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK, SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. INVESTORS SHOULD FURTHER UNDERSTAND THAT THIS INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. THE SECURITIES OFFERED HEREBY HA |
|
February 14, 2025 |
Exhibit 6.19 |
|
February 14, 2025 |
Exhibit 12.1 February 14, 2025 Board of Directors Limitless X Holdings Inc. 9777 Wilshire Blvd., Suite 400, Beverly Hills, CA 90212 To the Board of Directors: We have acted as counsel to Limitless X Holdings Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing of its offering statement on Form 1-A, (the “Offering Statement”) with the Securities and Exchange C |
|
February 14, 2025 |
Exhibit 6.20 |
|
February 14, 2025 |
[Preliminary] Offering Circular dated February [●], 2025 File No. 024-12515 [Preliminary] Offering Circular dated February [●], 2025 An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this [Preliminary] Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering |
|
February 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 7, 2025 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commissi |
|
February 11, 2025 |
Exhibit 10.1 |
|
February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 29, 2025 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commissi |
|
January 30, 2025 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 24, 2025 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commissi |
|
January 27, 2025 |
Exhibit 10.1 LIMITLESS X HOLDINGS INC. CONSULTANT AGREEMENT This Consultant Agreement (this “Agreement”) is entered into as of this January 24, 2025, by and between Limitless X Inc. (the “Company”), and Limitless Performance Inc. (the “Consultant”). WHEREAS, The Consultant owns the intellectual property from certain brands, including but not limited to NZT-48 and The Limitless Pill, and manufactur |
|
January 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 23, 2025 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commissi |
|
January 27, 2025 |
Exhibit 10.2 FIRST AMENDMENT TO MANUFACTURING AND DISTRIBUTORSHIP LICENSE AGREEMENT THIS FIRST AMENDMENT TO MANUFACTURING AND DISTRIBUTORSHIP LICENSE AGREEMENT (this “Amendment”) is effective as of January 24, 2025, by and between Limitless X, Inc., a Nevada corporation (“LimitlessX” or “Manufacturer”) and Limitless Performance Inc., a California corporation (“LPI” and together with the LimitlessX |
|
January 27, 2025 |
Exhibit 3.1 |
|
January 15, 2025 |
Exhibit 10.1 January 9, 2025 CONFIDENTIAL SETTLEMENT COMMUNICATION On [●] you entered into an employment agreement (Exhibit A) with Limitless X Holdings, Inc. (the “Company”). The Agreement provided that you would be paid minimum wage until the Company was sufficiently liquid to pay your cash salary as contemplated by that agreement. Due to continued cash flow challenges, and in exchange for your |
|
January 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 9, 2025 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commissio |
|
January 15, 2025 |
Exhibit 10.2 DEBT CONVERSION AGREEMENT This Debt Conversion Agreement (referred to as this “Agreement”), dated as of [●] (the “Closing Date”), is entered into by and between Limitless X Holdings, Inc., a Delaware corporation (the “Company”), and [●] (the “Creditor”). The parties to this Agreement may be referred to individually as a “Party” and collectively as the “Parties.” RECITALS: WHEREAS, the |
|
January 15, 2025 |
Exhibit 3.1 |
|
January 8, 2025 |
Certificate of Designation of Class C Convertible Preferred Stock of Limitless X Holdings Inc. Exhibit 3.1 |
|
January 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 2, 2025 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commissio |
|
December 31, 2024 |
Exhibit 10.1 PROMISSORY NOTE $200,000.00 Wilmington, Delaware Maturity Date: Six Months (or on funding) Effective Date: December 31, 2024 1. LOAN AMOUNT Principal Loan Amount: The sum of $200,000.00 (“Loan Amount” or “Loan”) payable in favor of Limitless X Holdings Inc. (the “Maker” or the “Company”) specifically for the retainer fee for the 2024 audit as well as additional securities attorney’s i |
|
December 31, 2024 |
Exhibit 10.2 LIMITLESS X HOLDINGS INC. CONSULTANT COMPENSATION AGREEMENT This Consultant Compensation Agreement (this “Agreement”) is entered into as of this December 21, 2024, by and between Limitless X Inc. (the “Company”), and Kourous Ghasaban (the “Consultant”). RECITALS WHEREAS, Consultant has experience in public relations, marketing, videography and brand awareness and influence; and WHEREA |
|
December 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 31, 2024 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commiss |
|
December 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
December 20, 2024 |
Exhibit 99.1 Limitless Horizons: A Vision for Growth, Innovation, and Shareholder Value at Limitless X Holdings Inc. LOS ANGELES, CA, December 20, 2024 - Limitless X Holdings, Inc. (OTCQB: LIMX), a celebrity-supported direct response marketing company focused on creating and promoting ‘Look Good, Feel Great’ products across various online platforms. Dear Valued Shareholders, As Chairman and CEO of |
|
December 20, 2024 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 19, 2024 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-5643 81-1034163 (State or other jurisdiction of incorporation) (Commissi |
|
December 16, 2024 |
Promissory Note dated December 10, 2024 between the Company and the Holder Exhibit 10.1 PROMISSORY NOTE $145,000.00 Wilmington, Delaware Maturity Date: Six Months (or on funding) Effective Date: December 10, 2024 1. LOAN AMOUNT Principal Loan Amount: The sum of $145,000.00 (“Loan Amount” or “Loan”) payable in favor of Limitless X Holdings Inc. (the “Maker”) specifically for the re-audit fee, the securities attorney’s invoices, and recent marketing expenses, currently due |
|
December 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 10, 2024 Date of Report (Date of earliest event reported) LIMITLESS X HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commiss |
|
December 3, 2024 |
Exhibit 10.12 |
|
December 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 000-56453 Commission File Numb |
|
November 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-56453 CUSIP NUMBER 090622309 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September |
|
September 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 20, 2024 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commis |
|
September 26, 2024 |
Exhibit 3.1 |
|
September 16, 2024 |
Exhibit 10.1 SETTLEMENT AGREEMENT AND RELEASE OF CLAIMS This Settlement Agreement and Release of Claims (“Agreement”) is entered into by and between Limitless X Holdings, Inc. (“the Company”) and , an employee of Company (“Employee”). R E C I T A L S A. Employee has raised concerns that the Company owes Employee salary, which amounts are disputed; B. Employee and the Company desire to avoid any di |
|
September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 10, 2024 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commis |
|
August 14, 2024 |
Exhibit 3.1 |
|
August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
July 18, 2024 |
RESIGNATION OF DIRECTOR July 18, 2024 Exhibit 99.1 RESIGNATION OF DIRECTOR July 18, 2024 Limitless X Holdings Inc. 9454 Wilshire Blvd. #300 Beverly Hills, CA 90212 Re: Notice of Resignation To whom it may concern: I resign as a director of Limitless X Holdings Inc., effective immediately. My resignation is not because of a disagreement with Limitless X Holdings Inc. on any matter relating to its operations, policies, or practices. Sin |
|
July 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 18, 2024 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction of incorporation) (Commission |
|
May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-56453 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Tra |
|
May 14, 2024 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission (I.R.S. Employer of |
|
April 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 000-56453 Commission File Number LIMITLESS X HOL |
|
April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response....2.50 FORM 12b-25 SEC FILE NUMBER 000-56453 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ T |
|
February 14, 2024 |
Exhibit 4.2 LIMITLESS X HOLDINGS INC. 2022 RESTRICTED STOCK PLAN 1. Purpose This Limitless X Holdings Inc. 2022 Restricted Stock Plan (this “Plan”) is intended to provide incentives which will attract, retain, motivate, and reward executive officers, non-employee directors, and other key employees of Limitless X Holdings Inc., a Delaware corporation (the “Company”) or any of its Affiliates, by pro |
|
February 14, 2024 |
As filed with the U.S. Securities and Exchange Commission on February 14, 2024. As filed with the U.S. Securities and Exchange Commission on February 14, 2024. Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LIMITLESS X HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 47910 81-1034163 (State or Other Jurisdiction of Incorporation or O |
|
February 14, 2024 |
Exhibit 21.1 List of Subsidiaries: 1. Prime Time Live- Colorado Corp 2. Limitless X Inc. – Nevada Corp |
|
February 14, 2024 |
Exhibit 4.3 LIMITLESS X HOLDINGS INC. 2022 INCENTIVE AND NONSTATUTORY STOCK OPTION PLAN 1. Purpose This Incentive and Nonstatutory Stock Option Plan (the “Plan”) is intended to further the growth and financial success of Limitless X Holdings Inc., a Delaware corporation (the “Company”) by providing additional incentives to selected employees, directors, and consultants to the Company or parent cor |
|
February 14, 2024 |
Calculation of Filing Fee Tables Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) LIMITLESS X HOLDINGS, INC. |
|
February 14, 2024 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF LIMITLESS X HOLDINGS INC., A DELAWARE CORPORATION TABLE OF CONTENTS TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 Section 1.1 Registered Office and Agent 1 Section 1.2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 2.1. Place of Meetings 1 Section 2.2. Annual Meetings 1 Section 2.3. Special Meetings 1 Section 2.4. Notice of Stockhol |
|
February 14, 2024 |
Amended Certificate of Designation of Class B Preferred Convertible Stock Exhibit 3.7 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF DESIGNATION OF CLASS B CONVERTIBLE PREFERRED STOCK OF LIMITLESS X HOLDINGS INC., a Delaware corporation Limitless X Holdings Inc., (the “Company”) a corporation organized and existing under and by virtue of the Delaware General Corporation Law (the “DGCL”), does hereby certify that the following resolution was duly adopted by the Board of Dire |
|
December 20, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 18, 2023 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission (I.R.S. Employ |
|
December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
November 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number: 000-56453 CUSIP Number: 090622309 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ |
|
November 6, 2023 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 1, 2023 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission (I.R.S. Employe |
|
October 26, 2023 |
Certificate of Designation of Class B Convertible Preferred Stock filed October 23, 2023 Exhibit 3.1 |
|
October 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 23, 2023 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission (I.R.S. Employe |
|
August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
June 6, 2023 |
Funding Commitment Agreement, dated June 3, 2023 Exhibit 10.2 FUNDING COMMITMENT AGREEMENT This FUNDING COMMITMENT AGREEMENT (this “Agreement”) is entered into on June 3, 2023 (the “Effective Date”) by and between Limitless X Holdings Inc., a Delaware corporation (the “Company”) and Jaspreet Mathur, an individual (the “Lender”). WHEREAS, the Company seeks working capital for the Company in order to continue to move forward with its business plan |
|
June 6, 2023 |
Agreement for Purchase and Sale of Stock, dated June 1, 2023 Exhibit 10.1 AGREEMENT FOR PURCHASE AND SALE OF STOCK This Agreement for Purchase and Sale of Stock (“Agreement”) is made as of June 1, 2023, by and among Limitless X Holdings Inc. (“Seller”) and Emblaze One, Inc. (“Buyer”). The stock that is the subject of this Agreement (hereinafter “Stock”) is 5,000 shares of capital stock of Vybe Labs, Inc., a Delaware corporation (hereinafter “the Corporation |
|
June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 1, 2023 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission File Number) (I.R.S |
|
May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
April 17, 2023 |
Exhibit 4.3 LIMITLESS X HOLDINGS INC. 2022 INCENTIVE AND NONSTATUTORY STOCK OPTION PLAN 1. Purpose This Incentive and Nonstatutory Stock Option Plan (the “Plan”) is intended to further the growth and financial success of Limitless X Holdings Inc., a Delaware corporation (the “Company”) by providing additional incentives to selected employees, directors, and consultants to the Company or parent cor |
|
April 17, 2023 |
Exhibit 4.2 LIMITLESS X HOLDINGS INC. 2022 RESTRICTED STOCK PLAN 1. Purpose This Limitless X Holdings Inc. 2022 Restricted Stock Plan (this “Plan”) is intended to provide incentives which will attract, retain, motivate, and reward executive officers, non-employee directors, and other key employees of Limitless X Holdings Inc., a Delaware corporation (the “Company”) or any of its Affiliates, by pro |
|
April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 000-56453 Commission file number LIMITLESS X HOL |
|
April 17, 2023 |
Exhibit 4.6 DESCRIPTION OF CAPITAL STOCK This summary does not purport to be complete. It is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation (the “certificate of incorporation”) and our Amended and Restated Bylaws (the “bylaws”), each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this E |
|
April 17, 2023 |
Exhibit 21.1 List of the Registrant’s Subsidiaries Limitless X, Inc. (Nevada) Prime Time Live, Inc. (Colorado) Vybe Labs, Inc. (Delaware) |
|
April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number: 000-56453 CUSIP Number: 090622309 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Fiscal Year Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11- |
|
February 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 29, 2023 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission File Number) (I |
|
February 2, 2023 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF LIMITLESS X HOLDINGS INC., A DELAWARE CORPORATION TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 Section 1.1 Registered Office and Agent 1 Section 1.2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 2.1. Place of Meetings 1 Section 2.2. Annual Meetings 1 Section 2.3. Special Meetings 1 Section 2.4. Notice of Stockholders’ Meetings 2 S |
|
January 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 11, 2023 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission File Number) (I |
|
December 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 19, 2022 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission File Number) ( |
|
December 21, 2022 |
EX-3.1 2 ea170620ex3-1limitless.htm CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION FILED DECEMBER 19, 2022 Exhibit 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Limitless X Holdings Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”) does hereby |
|
November 10, 2022 |
DEF 14C 1 ea168434-def14climitless.htm DEFINITIVE INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitiv |
|
November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A Amendment No. 1 For Registration of Certain Classes of Securities Pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 LIMITLESS X HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 81-1034163 (State or other jurisdiction of incorporation or organization) (I.R.S. Empl |
|
November 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 31, 2022 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission File Number) (I |
|
November 1, 2022 |
Amended and Restated Certificate of Incorporation filed October 31, 2022 EX-3.1 2 ea167885ex3-1limitless.htm AMENDED AND RESTATED CERTIFICATE OF INCORPORATION FILED OCTOBER 31, 2022 Exhibit 3.1 State of Delaware Secretary of State Division of Corporations Delivered 02:30 PM 10/31/2022 FILED 02:30 PM 10/31/2022 SR 20223900993 - File Number 4864845 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIMITLESS X HOLDINGS INC. Limitless X Holdings Inc., a corporation orga |
|
October 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement LIMITLESS X HOLDINGS INC. (Name of Registrant As |
|
October 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 3, 2022 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission File Number) (I. |
|
August 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement LIMITLESS X HOLDINGS INC. (Name of Registrant As |
|
August 29, 2022 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 24, 2022 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction (Commission File Number) (I. |
|
August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 000-56453 LIMITLESS X HOLDINGS INC. |
|
August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement LIMITLESS X HOLDINGS INC. (Name of Registrant As |
|
August 5, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 2, 2022 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (f/k/a Bio Lab Naturals Inc.) (Exact name of Registrant as specified in its charter) Delaware 000-56453 81-1034163 (State or other jurisdiction |
|
August 5, 2022 |
Amendment to Share Exchange Agreement, dated August 2, 2022 EX-10.1 2 ea163860ex10-1limitless.htm AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT, DATED AUGUST 2, 2022 Exhibit 10.1 Amendment No. 1 to SHARE EXCHANGE AGREEMENT This Amendment No.1 to Share Exchange Agreement (this “Agreement”) is entered into as of August 2nd, 2022 (the “Effective Date”) by and among Limitless X Holdings Inc., f/k/a Bio Lab Naturals, Inc., a Delaware corporation (the “Company”), |
|
June 17, 2022 |
Exhibit 99.1 |
|
June 17, 2022 |
REGISTRATION OF A CLASS OF SECURITIES - FORM 8-A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
June 17, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2022 Date of Report (Date of earliest event reported) Limitless X Holdings Inc. (f/k/a Bio Lab Naturals Inc.) (Exact name of Registrant as specified in its charter) Delaware 333-239640 81-1034163 (State or other jurisdiction |
|
June 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 1, 2022 Date of Report (Date of earliest event reported) Bio Lab Naturals, Inc. (Exact name of Registrant as specified in its charter) Delaware 333-239640 81-1034163 (State or other jurisdiction (Commission File Number) (I.R.S. |
|
June 8, 2022 |
Exhibit 99.1 ACTION BY WRITTEN CONSENT OF DIRECTORS (Section 222, Delaware General Corporation Law) OF Bio Lab Naturals Inc. A Delaware Corporation The undersigned, being all directors (the ?Directors?) of Bio Lab Naturals Inc., a Delaware Corporation, (the "Company"), pursuant to the Bylaws of the Company and Delaware General Corporation Law, hereby consents in writing to the following actions of |
|
June 8, 2022 |
Exhibit 99.2 ACTION BY WRITTEN CONSENT OF SHAREHOLDERS (Section 222, Delaware General Corporation Law) OF BIO LAB NATURALS INC. A Delaware Corporation The undersigned shareholders holding and possessing a majority of the issued and outstanding shares of Common Stock of Bio Lab Naturals Inc., a Delaware Corporation (the ?Company?), by their signature(s) below or on a counterpart hereof, hereby adop |
|
May 26, 2022 |
EXHIBIT 10.4 MANUFACTURING & DISTRIBUTORSHIP LICENSE AGREEMENT This AGREEMENT is entered into as of December 1, 2021, between SMILZ INC. (?Smilz?), a California corporation located at 4935 Mcconnell Ave., Suite 3, Los Angeles, California, and LIMITLESS X INC. (?LimitlessX? or ?Manufacturer?), a Nevada Corporation located at 9454 Wilshire Blvd., Suite 300, Beverly Hills, California. A. Smilz has de |
|
May 26, 2022 |
Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated February 11, 2022 EXHIBIT 10.8 PROMISSORY NOTE $150,000.00 Los Angeles, California 12-Month Note Effective Date: February 11, 2022 1. MAKER'S PROMISE TO PAY For value received, specifically a loan to pay for Sunset marketing events, Limitless X Inc. (referred to as ?Maker?), promises to pay to the order of ?Jaspreet Mathur?, including his agents, officers, successors, and assigns (collectively referred to as the ?H |
|
May 26, 2022 |
EXHIBIT 10.2 FORM OF CONSULTING AGREEMENT This Consulting Agreement (the ?Agreement?), effective as of May , 2022 (the ?Effective Date?) is by and between Bio Lab Naturals, Inc., a Delaware corporation (the ?Company?) and (the ?Consultant?). WHEREAS, the Company desires to engage Consultant, as an independent contractor, to perform certain services for the Company and Consultant desires to perform |
|
May 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 25, 2022 Date of Report (Date of earliest event reported) Bio Lab Naturals, Inc. (Exact name of Registrant as specified in its charter) Delaware 333-239640 81-1034163 (State or other jurisdiction (Commission File Number) (I.R.S. |
|
May 26, 2022 |
Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated May 8, 2022 EXHIBIT 10.9 PROMISSORY NOTE $550,000.00 Los Angeles, California 12-Month Note Effective Date: May 8, 2022 1. MAKER'S PROMISE TO PAY For value received, specifically a loan to cover multiple invoices, Limitless X Inc. (referred to as ?Maker?), promises to pay to the order of ?Jaspreet Mathur?, including his agents, officers, successors, and assigns (collectively referred to as the ?Holder?), at 94 |
|
May 26, 2022 |
EX-10.6 8 ex106.htm MANUFACTURING AND DISTRIBUTORSHIP LICENSE AGREEMENT BETWEEN REGISTRANT AND AMAROSE INC., DATED AS OF DECEMBER 1, 2021 EXHIBIT 10.6 MANUFACTURING & DISTRIBUTORSHIP LICENSE AGREEMENT This AGREEMENT is entered into as of December 1, 2021, between AMAROSE INC.. (hereinafter referred to as “Amarose”), a Florida corporation located at 515 E Las Olas Blvd., Ste Fort Lauderdale, Florid |
|
May 26, 2022 |
Limitless X Goes Public, Completes Previously Announced Share Exchange With Bio Lab Naturals, Inc EXHIBIT 99.1 Limitless X Goes Public, Completes Previously Announced Share Exchange With Bio Lab Naturals, Inc LOS ANGELES, May 23, 2022 /PRNewswire/ - Bio Lab Naturals, (?the Company?) (OTCQB:BLAB) announced that the Company and the shareholders of Limitless X, a creative and empowering lifestyle agency that has launched numerous industry-leading products in the dietary and CBD supplement sectors |
|
May 26, 2022 |
Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated December 6, 2021 EXHIBIT 10.7 PROMISSORY NOTE $50,000.00 Los Angeles, California 12-Month Note Effective Date: December 6, 2021 1. MAKER'S PROMISE TO PAY For value received, specifically a loan for initial start-up costs, to pay for Sunset marketing events, Limitless X Inc. (referred to as ?Maker?), promises to pay to the order of ?Jaspreet Mathur?, including his agents, officers, successors, and assigns (collecti |
|
May 26, 2022 |
EXHIBIT 10.1 Lock-Up/Leak Out Agreement May 11 , 2022 Bio Lab Naturals, Inc. 7400 East Crestline Circle Suite 130 Greenwood Village Colorado 80111 Attention Chief Executive Officer Limitless X Inc. 9454 Wilshire Boulevard Suite 300 Beverly Hills, California 90212 Attention Jas Mathur, Chief Executive Officer Ladies and Gentlemen: In connection with that certain Share Exchange Agreement by and amon |
|
May 26, 2022 |
Amended Certificate of Designation of Class A Preferred Convertible Stock EXHIBIT 3.1 AMENDED CERTIFICATE OF DESIGNATION OF SERIES A PREFERRED CONVERTIBLE STOCK OF BIO LAB NATURALS, INC. A Delaware Corporation It is hereby certified that: 1. The name of the Company (hereinafter called the "Company") is Bio Lab Naturals, Inc., a Delaware corporation. 2. Pursuant to Section 151 of the Delaware General Corporation Law, the Certificate of Incorporation of the Company author |
|
May 26, 2022 |
EXHIBIT 10.3 MANUFACTURING & DISTRIBUTORSHIP LICENSE AGREEMENT This AGREEMENT is entered into as of December 1, 2021, between DIVATRIM INC. (hereinafter referred to as ?Divatrim?), a Florida corporation located at 515 E Las Olas Blvd., Ste 120 Fort Lauderdale, Florida 33301, and LIMITLESS X INC. (?LimitlessX?), a Nevada Corporation located at 9454 Wilshire Blvd., Suite 300, Beverly Hills, Californ |
|
May 26, 2022 |
Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated May 18, 2022 EX-10.11 13 ex1011.htm LIMITLESS X INC. PROMISSORY NOTE IN AMOUNT OF $450,000, DATED AS OF MAY 18, 2022 PROMISSORY NOTE $450,000.00 Los Angeles, California 30-Day Repayment Effective Date: May 18, 2022 1. MAKER'S PROMISE TO PAY For value received, specifically a loan to pay invoices from third party advertiser network company, Limitless X Inc. (referred to as “Maker”), promises to pay to the order |
|
May 26, 2022 |
Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated May 16, 2022 EX-10.10 12 ex1010.htm LIMITLESS X INC. PROMISSORY NOTE IN AMOUNT OF $1,100,000, DATED AS OF MAY 16, 2022 EXHIBIT 10.10 PROMISSORY NOTE $1,100,000.00 Los Angeles, California 30-Day Repayment Effective Date: May 16, 2022 1. MAKER'S PROMISE TO PAY For value received, specifically a loan to pay invoices from third party advertiser network company, Limitless X Inc. (referred to as “Maker”), promises t |
|
May 26, 2022 |
EXHIBIT 10.5 MANUFACTURING & DISTRIBUTORSHIP LICENSE AGREEMENT This AGREEMENT is entered into as of December 1, 2021, between Limitless Performance Inc. (hereinafter referred to as ?LPI?), a California corporation located at 1801 Century Park East, 24th Floor, Los Angeles, CA 90067, and LIMITLESS X INC. (?LimitlessX? or ?Manufacturer?), a Nevada Corporation located at 9454 Wilshire Blvd., Suite 30 |
|
May 13, 2022 |
Exhibit 10.1 SHARE EXCHANGE AGREEMENT dated as of May 11, 2022 by and among Bio Lab Naturals, Inc., a Delaware corporation, on the one hand and Limitless X, Inc., a California corporation, Jaspreet Mathur, an individual, and Jaspreet Mathur, and the other Exchanging Shareholders of Limitless X, Inc. listed on Schedule A hereto on the other hand SHARE EXCHANGE AGREEMENT This Share Exchange Agreemen |
|
May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2022 Date of Report (Date of earliest event reported) Bio Lab Naturals, Inc. (Exact name of Registrant as specified in its charter) Delaware 333-239640 81-1034163 (State or other jurisdiction (Commission File Number) (I.R.S. |
|
May 10, 2022 |
As filed with the Securities and Exchange Commission on May 10 , 2022 As filed with the Securities and Exchange Commission on May 10 , 2022 Registration No. |
|
May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 333-239640 BIO LAB NATURALS, INC. |
|
April 26, 2022 |
As filed with the Securities and Exchange Commission on April 25 , 2022 As filed with the Securities and Exchange Commission on April 25 , 2022 Registration No. |
|
March 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-239640 Commission file number Bio Lab Natura |
|
November 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 333-239640 BIO LAB NATURALS, INC. |
|
July 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X]QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 333-239640 BIO LAB NATURALS, INC. |
|
May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 333-239640 BIO LAB NATURALS, INC. |
|
March 31, 2021 |
EXHIBIT 99.1 Bio Lab Naturals, Inc., a Delaware corporation (BLAB: OTC) announces entry into a Lease/Purchase Agreement. Denver, CO / Accesswire / March 30, 2021 / Bio Lab Naturals, Inc., a Delaware corporation, "BLAB" (OTCQB: BLAB), based in Denver, Colorado, desires to provide information to its investors and shareholders related to a Lease/Purchase Agreement dated March 24, 2021. On March 24, 2 |
|
March 31, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 30, 2021 Bio Lab Naturals, Inc. (Exact name of registrant as specified in its charter) Delaware 333-239640 84-2288662 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identif |
|
March 22, 2021 |
EXHIBIT 99.1 Bio Lab Naturals, Inc. a Delaware corporation, (BLAB:OTC) Addresses a Yahoo Press Release containing Information that was not Applicable to the Company For Immediate Release: Bio Lab Naturals, Inc., a Delaware corporation, "BLAB" (OTCQB) based in Denver, Colorado wishes to clear up any confusion as to a news release dated January 6, 2020, that appears on Yahoo Finance on the quote pag |
|
March 22, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 22, 2021 Bio Lab Naturals, Inc. (Exact name of registrant as specified in its charter) Delaware 333-239640 84-2288662 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identif |
|
March 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-239640 Commission file number Bio Lab Natura |
|
December 15, 2020 |
As filed with the Securities and Exchange Commission on December 14, 2020 Registration No. |
|
November 18, 2020 |
Bio Lab Naturals, Inc.’s subsidiary signs Exclusive Distribution Agreement EXHIBIT 99.1 Bio Lab Naturals, Inc.’s subsidiary signs Exclusive Distribution Agreement Greenwood Village, CO November 18, 2020, Bio Lab Naturals, Inc. (“BLAB” or the “Company”) (QTCQB: BLAB) announces today that its subsidiary, Prime Time Live, Inc. (“PTL”) signed an Exclusive Distribution Agreement on November 13, 2020 with Insane Impact, LLC (“Insane Impact”), an Iowa limited liability company, |
|
November 18, 2020 |
Exclusive Distribution Agreement EXHIBIT 10.1 Exclusive Distribution Agreement THIS EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is entered into effective as of November 13th, 2020 (the “Effective Date”) by and between Insane Impact LLC, an Iowa limited liability company (“Insane Impact”) and Prime Time Live Inc., a Colorado corporation (“PTL”). The parties agree as follows: 1. Appointment a. Subject to the terms and condi |
|
November 18, 2020 |
8-K 1 biolab8knov182020.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 13, 2020 Bio Lab Naturals, Inc. (Exact name of registrant as specified in its charter) Delaware 333-239640 84-2288662 (State or other jurisdiction of incorporation) (Commission Fil |
|
November 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 30, 2020 Bio Lab Naturals, Inc. (Exact name of registrant as specified in its charter) Delaware 333-239640 84-2288662 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Ident |
|
November 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number: 333-239640 BIO LAB NATURALS, INC. |
|
October 20, 2020 |
Filed pursuant to Rule 424(b)(2) Registration No. 333-239640 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission and is effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting an offer to buy the |
|
October 14, 2020 | ||
October 7, 2020 |
============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
October 7, 2020 |
Michael A. Littman Attorney at Law PO Box 1839 Arvada, CO 80001 (720) 530-6184 [email protected] October 7, 2020 VIA EDGAR CORRESPONDENCE Securities and Exchange Commission Division of Corporation Finance Office of Trade and Services Washington, D. C. 20549 Re: Bio Lab Naturals, Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed September 23, 2020 File No. 333-239640 Dear Commission, |
|
September 23, 2020 |
Michael A. Littman Attorney at Law PO Box 1839 Arvada, CO 80001 (720) 530-6184 [email protected] September 23, 2020 VIA EDGAR CORRESPONDENCE Securities and Exchange Commission Division of Corporation Finance Office of Trade and Services Washington, D. C. 20549 Re: Bio Lab Naturals, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed August 14, 2020 File No. 333-239640 Dear Commission, |
|
September 23, 2020 |
============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
September 2, 2020 |
Michael A. Littman Attorney at Law PO Box 1839 Arvada, CO 80001 (720) 530-6184 September 2, 2020 VIA EDGAR CORRESPONDENCE Securities and Exchange Commission Division of Corporate Finance Washington, D. C. 20549 Attn: Scott Stringer Re: Bio Lab Naturals, Inc. Amendment No. 1 to Registration Statement on Form S-1 File No. 333-239640 Dear Mr. Stringer, On behalf of the Issuer, I am responding to comm |
|
August 14, 2020 |
============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
August 14, 2020 |
Michael A. Littman Attorney at Law P.O. Box 1839 Arvada, CO 80001 (720) 530-6184 [email protected] August 14, 2020 VIA EDGAR United States Securities & Exchange Commission Division of Corporation Finance Office of Trades and Services Attn: Scott Stringer or Theresa Brillant Washington, D.C. 20549 Re: Bio Lab Naturals, Inc. Registration Statement on Form S-1 Filed July 2, 2020 File No. 333-239640 D |
|
July 2, 2020 | ||
July 2, 2020 |
Certification of Amendment of Certificate of Incorporation (Article 4) filed February 3, 2020 |
|
July 2, 2020 | ||
July 2, 2020 |
EX-21.1 25 ex21.htm EXHIBIT 21 LIST OF SUBSIDIARIES Prime Time Live, Inc. – a Colorado corporation |
|
July 2, 2020 | ||
July 2, 2020 | ||
July 2, 2020 |
Certificate of Incorporation of Bio Lab Naturals, Inc. filed August 26, 2010 |
|
July 2, 2020 | ||
July 2, 2020 | ||
July 2, 2020 |
S-1 1 blabforms1.htm ============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BIO LAB NATURALS, INC. (Exact name of registrant as specified in its charter) DELAWARE (State or jurisdiction of incorporation or organization) 7312 (Primary Stand |
|
July 2, 2020 |
Bylaws of PTL Acquisition Sub, Inc. EXHIBIT 3(ii).17 BYLAWS OF PTL ACQUISITION SUB, INC. Article I SHAREHOLDERS 1. ANNUAL SHAREHOLDERS' MEETING. The annual shareholders' meeting shall be held on the date and at the time and place fixed from time to time by the Board of Directors. 2. SPECIAL SHAREHOLDERS' MEETING. A special shareholders' meeting for any purpose or purposes, may be called by the Board of Directors or the president. Th |
|
July 2, 2020 |
EX-3.7 8 ex37.htm |
|
July 2, 2020 |
Class A Super Majority Convertible Preferred Shares Designation filed February 5, 2020 EX-4.3 21 ex43.htm |
|
July 2, 2020 |
Certificate of Incorporation of Vyta Corp. filed June 3, 2010 EX-3.2 3 ex32.htm |
|
July 2, 2020 | ||
July 2, 2020 |
Statement of Correction of Prime Time Live filed September 17, 2019 EX-3.14 15 ex314.htm |
|
July 2, 2020 |
Agreement and Plan of Reorganization with Prime Time Live, Inc. EXHIBIT 10.1 AGREEMENT AND PLAN OF REORGANIZATION This Agreement and Plan of Reorganization ("Agreement") supercedes and replaces that Agreement of Merger between the parties made and entered into as of December 31, 2019 (the "Effective Date"), by and among Prime Time Live, Inc. , a Colorado corporation, with its principal office at 5770 S. Beech Court, Greenwood Village, Co. 80121 ("PTL"), and Bi |
|
July 2, 2020 |
Certificate of Incorporation of 10 Vyta, Inc. filed August 26, 2010 EX-3.5 6 ex35.htm |
|
July 2, 2020 |
EXHIBIT 3(ii).16 BYLAWS OF BIO LAB NATURALS, INC. Article I SHAREHOLDERS 1. ANNUAL SHAREHOLDERS' MEETING. The annual shareholders' meeting shall be held on the date and at the time and place fixed from time to time by the Board of Directors. 2. SPECIAL SHAREHOLDERS' MEETING. A special shareholders' meeting for any purpose or purposes, may be called by the Board of Directors or the president. The C |
|
July 2, 2020 | ||
July 2, 2020 | ||
July 2, 2020 |
Certificate of Correction - Voiding Name Change filed March 27, 2015 EX-3.8 9 ex38.htm |
|
July 2, 2020 |
Certificate of Amendment of Certificate of Incorporation of Vyta Corp. filed August 26, 2010 EX-3.3 4 ex33.htm |
|
July 2, 2020 | ||
July 2, 2020 |
EXHIBIT 4.1 2020 BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE PLAN SECTION 1: GENERAL PURPOSE OF PLAN The name of this plan is the BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE PLAN (the "Plan"). The purpose of the Plan is to enable BIO LAB NATURALS, INC., a Delaware corporation (the "Company"), and any Parent or any Subsidiary to obtain and retain the services of the types of |